A Clinical Study to Evaluate the Pharmacokinetic Profile of SB-649868 in Elderly and Female Population

• Status: Withdrawn
• Trial end date: 2007-10-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine the blood levels and the tolerability of SB-649868 in Elderly and Female population

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: GlaxoSmithKline

Criteria

INCLUSION CRITERIA:

• Healthy adult and elderly female and male

• Female must be of non-childbearing potential

• Body weight =50 kg

EXCLUSION CRITERIA:

• Abuse of alcohol or drugs

• Positive for Hepatitis B surface antigen, Hepatitis C antibody or HIV

• Use of prescription or non-prescription drugs within 7 days prior to the first dose of study medication

• Smoking history of = 10 cigarettes a day in the last three months

• History of cardiovascular,psychiatric,autoimmune, respiratory or relevant gastrointestinal diseases

• Participation in clinical trial during the previous 6 months